About KoBioLabs
KoBioLabs is a company based in Seoul (South Korea) founded in 2014.. The company has 57 employees as of December 31, 2024. KoBioLabs operates in a competitive market with competitors including Kriya Therapeutics, DermBiont, Trace Genomics, Vedanta Biosciences and Inozyme Pharma, among others.
- Headquarter Seoul, South Korea
- Employees 57 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Kobiolabs, Inc.
-
Annual Revenue
$47.95 M (USD)1.36as on Dec 31, 2025
-
Net Profit
$-4.86 M (USD)-32.46as on Dec 31, 2025
-
EBITDA
$-2.94 M (USD)74.46as on Dec 31, 2024
-
Latest Funding Round
- Investors
-
Employee Count
57
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of KoBioLabs
KoBioLabs is a publicly listed company on the KRX with ticker symbol 348150 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of KoBioLabs
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2014 | Amount | Series A - KoBioLabs | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in KoBioLabs
KoBioLabs has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Stonebridge Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage tech and life sciences focused VC & PE firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by KoBioLabs
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - KoBioLabs
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kobiolabs Comparisons
Competitors of KoBioLabs
KoBioLabs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kriya Therapeutics, DermBiont, Trace Genomics, Vedanta Biosciences and Inozyme Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| domain | founded_year | HQ Location |
Microbial therapeutics for skin diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of technologies to diagnose soil health and soil-borne disease prediction
|
|
| domain | founded_year | HQ Location |
Therapeutics for infectious and autoimmune diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of treatments for rare and debilitating metabolic diseases
|
|
| domain | founded_year | HQ Location |
The gut-brain axis is explored for therapeutic and nutritional innovations.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kobiolabs
Frequently Asked Questions about KoBioLabs
When was KoBioLabs founded?
KoBioLabs was founded in 2014.
Where is KoBioLabs located?
KoBioLabs is headquartered in Seoul, South Korea.
Who is the current CEO of KoBioLabs?
GwangPyo Ko is the current CEO of KoBioLabs.
How many employees does KoBioLabs have?
As of Dec 31, 2024, the latest employee count at KoBioLabs is 57.
What is the annual revenue of KoBioLabs?
Annual revenue of KoBioLabs is $47.95M as on Dec 31, 2025.
What does KoBioLabs do?
KoBioLabs was founded in 2014 in Seoul, South Korea, within the biotechnology sector. Focus is placed on microbiome-based therapeutics, companion diagnostics, and medicinal foods targeting inflammatory bowel diseases, metabolic syndromes, C. difficile infections, immune disorders, and mental health conditions. Diagnostic biomarkers and medical foods, including probiotics, prebiotics, and synbiotics, are also developed. The pipeline encompasses CUREbiotics for therapies and CAREbiotics for nutritional products.
Who are the top competitors of KoBioLabs?
KoBioLabs's top competitors include Ardelyx, Trace Genomics and Vedanta Biosciences.
Is KoBioLabs publicly traded?
Yes, KoBioLabs is publicly traded on KRX under the ticker symbol 348150.
Who are KoBioLabs's investors?
KoBioLabs has 1 investor. Key investors include Stonebridge Capital.
What is KoBioLabs's ticker symbol?
The ticker symbol of KoBioLabs is 348150 on KRX.